| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.884 | 47.868 | - | 60.733 | 62.244 | 56.088 | 58.457 | 55.898 | 59.005 | 58.800 |
| Total Income - EUR | 38.085 | 47.957 | - | 65.117 | 63.159 | 56.253 | 58.647 | 57.016 | 59.036 | 59.118 |
| Total Expenses - EUR | 14.037 | 31.004 | - | 29.065 | 18.553 | 47.549 | 48.751 | 54.696 | 50.811 | 53.306 |
| Gross Profit/Loss - EUR | 24.048 | 16.953 | - | 36.051 | 44.606 | 8.704 | 9.896 | 2.320 | 8.224 | 5.812 |
| Net Profit/Loss - EUR | 23.504 | 16.283 | - | 34.000 | 43.019 | 8.146 | 9.249 | 1.236 | 7.634 | 5.221 |
| Employees | 0 | 0 | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Daderma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.010 | 1.989 | - | 1.920 | 1.883 | 5.982 | 5.849 | 5.867 | 5.849 | 5.817 |
| Current Assets | 76.662 | 90.198 | - | 126.511 | 164.620 | 116.905 | 122.474 | 103.362 | 88.778 | 26.374 |
| Inventories | 13.878 | 11.232 | - | 22.276 | 16.268 | 18.013 | 21.091 | 21.157 | 17.641 | 14.442 |
| Receivables | 35.829 | 43.947 | - | 75.012 | 73.043 | 83.441 | 83.637 | 76.877 | 67.458 | 6.620 |
| Cash | 26.955 | 35.020 | - | 29.223 | 75.309 | 15.450 | 17.745 | 5.328 | 3.679 | 5.311 |
| Shareholders Funds | 68.279 | 83.865 | - | 118.911 | 159.627 | 109.855 | 116.668 | 66.952 | 74.383 | 19.683 |
| Social Capital | 45 | 45 | - | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 11.079 | 9.002 | - | 9.520 | 6.876 | 13.031 | 7.055 | 16.573 | 8.770 | 12.507 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 4.600 | 25.703 | 11.474 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Daderma Srl